Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Trametinib

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Trametinib GSK1120212 MEK1/2 MAPK/ERK signaling Approved Phase 2 Selleck Chemicals S2673

Cell Line (34)
Cell LineAUCGI50
HepaRG0.290.016
JHH10.370.008
JHH50.40.022
HCC.1.20.450.047
SNU8780.450.08
Hep3B0.50.077
HepG20.50.008
SNU7610.640.305
Li70.660.51
HCC.1.10.691.055
MHCC97H0.7210.0
SNU8860.742.49
SNU3980.7510.0
JHH70.767.52
PLC.PRF50.7910.0


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it